Tomatoes, a key element of the Mediterranean diet, are a rich source of bioactive compounds that contribute positively to health. This review investigates how interactions between starch and tomato polyphenols and carotenoids impact starch digestibility and the glycaemic response. A key focus is the role of the food matrix and nutrient interactions, often overlooked in studies assessing individual compounds. We found that bioactive compounds from tomatoes can modulate starch digestion at the molecular level, and that the interactions between starch and bioactive compounds depend on the starch structure, type of bioactive compound, and complexation conditions. However, results from intervention studies assessing the effect of tomato bioactive compounds on glycemia in humans are not convincing and modest or non-significant changes were observed in glucose and insulin concentrations. This may be due to the lack of specific studies on glycemia and the diverse study populations, which complicate direct comparisons of results. Overall, this review highlights the importance of analyzing how nutrient interactions and the food matrix influence nutrient digestibility and absorption. Furthermore, we identify research gaps regarding the effects of consuming tomatoes or tomato-based products alongside starch-based foods, emphasizing the need for further targeted studies to clarify their role in glycaemic regulation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10408398.2025.2474177 | DOI Listing |
Iran J Pharm Res
December 2024
College of Traditional Chinese Medicine, Hebei North University, Zhangjiakou City, 075000, China.
Background: Herbal compounds sourced from various plants are becoming targeted therapies for breast cancer.
Objectives: This study aims to explore the potential of focusing on herbal compounds as targeted therapies for breast cancer using computational techniques.
Methods: A total of 129 herbal compounds linked with breast cancer were identified from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) database.
Iran J Pharm Res
December 2024
Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.
Background: The receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 interacts with the angiotensin-converting enzyme 2 (ACE2) receptor in humans. To date, numerous SARS-CoV-2 variants, particularly those involving mutations in the RBD, have been identified. These variants exhibit differences in transmission, pathogenicity, diagnostics, and vaccine efficacy.
View Article and Find Full Text PDFHeliyon
February 2025
INVIVO Co. Ltd., 121, Deahak-ro, Nonsan, Chungnam, 32992, Republic of Korea.
A by-product is a secondary substance unintentionally produced during manufacturing and can be repurposed through recycling. In particular, by-products generated from the processing of natural materials are valuable because of their bioactive compound content, such as polyphenols and anthocyanins. Obesity is a global health issue, and medicines for obesity have side effects, such as insomnia and headaches.
View Article and Find Full Text PDFFood Funct
March 2025
Department of Pharmacy, Faculty of Health Sciences, Universidad San Jorge, 50830, Zaragoza, Spain.
Apples ( Borkh.) are one of the most consumed fruits around the world with a high production of peels as wastes and by-products. In this work, peels from different commercial and local apple samples are explored as a source of phenolic bioactive compounds that could be directly related to the prevention of type 2 diabetes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!